Novel IGH and MYC Translocation Partners in Diffuse Large B-Cell Lymphomas

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• Chromosomal translocations involving immunoglobulin (IG) loci and proto-oncogenes are key in diffuse large B-cell lymphoma (DLBCL) pathogenesis.
• Common IG translocation partners include BCL6, BCL2, and MYC, but rarer partners also exist.

Purpose of the Study:

• To identify novel translocation partners in DLBCL by investigating IG heavy chain (IGH) locus-associated translocations and MYC translocations.
• To explore the pathogenetic role of newly identified translocation partners in DLBCL.

Main Methods:

• Fluorescence in situ hybridization (FISH) was used to identify IG locus-associated translocations.
• Long-distance inverse PCR (LDIPCR) was employed to pinpoint translocation partners.
• Gene expression analysis was performed to assess the impact of translocations.

Main Results:

• Three novel IGH-associated translocations were identified, involving IMMP2L (7q31), BCAS2 (1p13), and PVRL2 (19q13).
• PVRL2 showed significantly higher expression in DLBCL with the translocation, suggesting a pathogenetic role.
• A novel MYC-SOCS1 translocation was found, involving a proto-oncogene and a tumor suppressor gene, with evidence of oncogene deregulation and tumor suppressor inactivation.

Conclusions:

• Chromosomal translocations in DLBCL are more diverse than previously recognized.
• The identification of novel translocation partners like IMMP2L, BCAS2, and PVRL2 contributes to understanding DLBCL heterogeneity.
• The MYC-SOCS1 translocation highlights unusual oncogene-tumor suppressor interactions in DLBCL pathogenesis.